ADAM17 and Cholestatic liver disease: In the setting of cholestatic liver disease, both progressive liver damage and impaired liver regeneration have been attributed, in part, to the differential hepatic expression of the proinflammatory cytokines TNF-α and IL-6; the processing and subsequent biological effects of which are mediated by ADAM17 (15–18).